中西医结合治疗心律失常患者临床疗效观察及其安全性评价  

Clinical Observation and Safety Evaluation of Combined Chinese and Western Medicine in Treating Patients with Arrhythmia

作　　者：李英[1] 惠朋利[2] 

机构地区：[1]陕西省安康市中医院心血管科,陕西安康725000 [2]陕西省安康市中医院老年干部科,陕西安康725000

出　　处：《湖北中医药大学学报》2015年第5期25-27,共3页Journal of Hubei University of Chinese Medicine

基　　金：陕西省医药科技项目(201537494)

摘　　要：目的观察中西医结合治疗心律失常患者临床疗效观察及其安全性。方法 90例心律失常患者随机分为两组,治疗组采用中西医结合治疗,对照组仅给予西药治疗。两组疗程均为1个月。比较两组疗效、24h动态心电图变化、心电图心率及治疗期间不良反应发生情况。结果治疗组总有效率显著高于对照组(P<0.05);两组室性早搏和ST段压低治疗后较治疗前显著减少(P<0.05),且治疗组显著低于对照组(P<0.05);治疗组不良反应发生率显著低于对照组(P<0.05)。结论中西医结合治疗心律失常患者临床疗效显著,安全可靠,具有重要临床研究意义。Objective To observe the clinical efficacy and safety of combination therapy on patients with arrhythmia. Methods 90 cases of arrhythmia were randomly divided into two groups. The treatment group received the combination therapy,the control group received western medicine. The treatment lasted a month. Two groups of efficacy,24 h dynamic ECG changes,ECG heart rate and adverse reactions during treatment were compared. Results The total effective rate in treatment group was significantly higher than that of control group（ P〈0. 05）; two groups of premature ventricular contractions and ST segment depression after treatment was significantly lower than that before treatment（ P〈0. 05）,and the treatment group was significantly lower than that of the control group（ P〈0. 05）; the incidence of adverse reactions in the treatment group was significantly lower than that in the control group（ P〈0. 05）. Conclusions The clinical efficacy of integrative medicine therapy on arrhythmia patients is significant safety and reliability,has important clinical significance.

关 键 词：心律失常 中西医结合疗法 普罗帕酮 

分 类 号：R259[医药卫生—中西医结合]